Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy
about
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem CellsA new prospect in cancer therapy: targeting cancer stem cells to eradicate cancerHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsTranscriptome sequencing of tumor subpopulations reveals a spectrum of therapeutic options for squamous cell lung cancerOmega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy.Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer.HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Enrichment and characterization of cancer stem‑like cells from a cervical cancer cell line.Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activationProtein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations.Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsMammosphere formation assay from human breast cancer tissues and cell lines.Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 inhibition.All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy.Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatmentDiagnostic value of Wilms tumor 1 and CD44 in Langerhans cell sarcoma: case series of 4 patients.Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguityActivation of RARα induces autophagy in SKBR3 breast cancer cells and depletion of key autophagy genes enhances ATRA toxicity.CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.Low concentrations of 5-aza-2'-deoxycytidine induce breast cancer stem cell differentiation by triggering tumor suppressor gene expression.The implications of cancer stem cells for cancer therapy.Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like propertiesTargeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results.Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.CD44 targets Na(+)/H(+) exchanger 1 to mediate MDA-MB-231 cells' metastasis via the regulation of ERK1/2.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.Redox regulation in stem-like cancer cells by CD44 variant isoforms.CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.The cancer stem cell hypothesis: a guide to potential molecular targets.Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer.Biological and clinical significance of cancer stem cell plasticityAltered fate of tendon-derived stem cells isolated from a failed tendon-healing animal model of tendinopathy.Increased invasion and tumorigenicity capacity of CD44+/CD24- breast cancer MCF7 cells in vitro and in nude mice.Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack.A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells.
P2860
Q26853528-E4868A48-2D84-4FDD-9ABE-F8E44FD46E1BQ27022134-90FCE632-2DE2-4564-B8F2-48A632B8076DQ28393898-D81D2473-8002-47DE-B296-90141E140F16Q28488566-4B7861C2-1698-4074-BB75-CE8EF7186A82Q31123584-5B427DEE-34D3-4FF3-B984-14FD12498879Q33700204-438C0CC8-7BC3-44A3-B557-05AB18365428Q33737278-AB7A1F0A-1DAF-4E74-9214-4E60BC48973CQ33747768-8EF06521-9147-4043-ADD9-71AA22900E02Q33942068-D2CFD6CF-C131-4F4C-9922-33EA7620C579Q34383397-EA58470D-27E7-4284-B742-837722B73016Q35063763-B28B30F1-39E6-4889-A22B-5ACF3775368BQ35181463-33F57541-079C-4F9E-A0CB-A4B8489DF4EEQ35425337-4D0EBD41-2487-4AFF-B47D-5F8AD6FDF085Q35460919-DE3706DE-A07D-4B06-A924-4F791EED5949Q35550186-9637BB94-9B47-4467-8DF1-B740B5373251Q35830047-AACB8A04-7A12-447C-A826-536443E6EE85Q35977057-0935C174-9452-4DAD-9635-C85F8097A625Q35979751-95F66D2A-FB7C-4B11-8359-4246AE365971Q36009181-8A35EC31-35BB-4E41-985A-50CA4A748177Q36014411-74FA1A84-23E9-46E7-B418-32EA7DD0352DQ36022328-B792CF57-FA02-459E-B8E8-41F883D15BAFQ36260608-29E7C430-A964-43F4-B8E0-73C63A5F3E85Q36412709-5431A0DB-1C52-40F1-94CA-43B1B5705084Q36538487-70EA3840-F7B0-4007-BE9A-8567C66567F1Q37039311-11E0D4FE-7C5B-4798-A03F-DE2C868C8E77Q37123297-01E361EB-2970-4BAC-88A4-19B0DE0EEB73Q37295465-BE65F129-C745-4F44-B7DC-AA8C2D2C8F7EQ37420064-D694B5AE-70E5-44B5-9415-8FFB7CB5FB6CQ37594390-5A99757F-BCF0-4674-AF7E-03BB35AAE503Q37610799-F681A227-7BEB-4DC6-A191-FFC2630C3F57Q38045265-ED716917-0EFE-4785-994A-38743C583F17Q38075424-B40F7A1A-0F90-4960-91C4-57E3A3F65320Q38100108-326B8373-7C7F-4A18-9FC5-1664049B103EQ38254181-7D495838-9F6C-43D7-8A9C-EF374D08A07BQ38727418-6A336EA4-4456-4EBF-A553-8A987E45BC85Q38757074-C999413C-B73F-4AF5-A72C-8BF845C69219Q39293996-2C7F9CAD-6F10-4DC6-859C-19A3F89D2AB9Q39396696-C55362AC-0E49-4543-9D90-DA8D9D543DBAQ39443694-DBA72CC1-82DF-4717-B457-573FC1C93F90Q42049959-7A23AE2E-5A80-479D-B682-DE66D90E7B55
P2860
Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Differentiation of breast canc ...... mising differentiation therapy
@ast
Differentiation of breast canc ...... mising differentiation therapy
@en
type
label
Differentiation of breast canc ...... mising differentiation therapy
@ast
Differentiation of breast canc ...... mising differentiation therapy
@en
prefLabel
Differentiation of breast canc ...... mising differentiation therapy
@ast
Differentiation of breast canc ...... mising differentiation therapy
@en
P2093
P2860
P356
P1476
Differentiation of breast canc ...... mising differentiation therapy
@en
P2093
Kiet D Truong
Ngoc K Phan
Nhan L C Phan
Nhung H Truong
Nhung T Nguyen
Phuc V Pham
Thuy T Duong
P2860
P2888
P356
10.1186/1479-5876-9-209
P577
2011-12-07T00:00:00Z
P5875
P6179
1007742602